Urgent: Cannabis Syndrome “Scromiting” Surges 700% in U.S. ERs

UPDATE: A startling new report reveals that cases of a mysterious cannabis-related syndrome known as cannabinoid hyperemesis syndrome (CHS) have surged by 700% in U.S. emergency rooms from 2016 to 2022. The phenomenon, often referred to as “scromiting”—a painful combination of screaming and vomiting—has become a concerning health issue amid increasing cannabis legalization and potency.

Jared Panks, a paramedic and medical cannabis advocate from Oregon, was shocked when he began experiencing relentless vomiting episodes in 2013. After using marijuana to manage pain from scoliosis and knee injuries, Panks found himself unable to eat or retain fluids, often resorting to hot showers for temporary relief. “Sometimes it goes 14 days, where my whole body starts to seize up,” he stated, describing the brutal reality of his condition.

A new study conducted by the University of Illinois Chicago highlights troubling trends: CHS diagnoses peaked at 33 cases per 100,000 ER visits during the COVID-19 pandemic, coinciding with increased substance abuse rates. Most affected individuals are young adults aged 18 to 35, predominantly men, who consume high-potency cannabis products daily.

While cannabis is widely known for its appetite-stimulating properties, excessive use can lead to severe adverse reactions. Professor James Swartz, the lead author of the study, emphasizes that increased legalization and potency are primary factors behind the alarming rise in CHS cases. “There is still some skepticism,” he warned. “No, this is real, and it’s common enough that it’s of concern.”

Tim Blake, founder of the prestigious Emerald Cup, shared his personal battle with CHS, having experienced cyclic vomiting himself. After quitting cannabis for months to rid his body of THC, he now advocates for responsible consumption, comparing it to alcohol moderation. “We shouldn’t be drinking 151 rum shots every day,” he pointedly remarked.

As research into CHS remains in its early stages, the World Health Organization has only recently recognized it as a legitimate medical condition. Patients like Alice Moon are calling for more studies to better understand the syndrome’s causes and potential treatments. “I promote a substance I cannot consume,” she admitted, stressing the importance of spreading awareness.

The findings urge users to reconsider their cannabis consumption habits and be aware of potential risks. Panks is determined to participate in further studies to explore the science behind CHS, advocating for a focus on cannabis terpenes rather than just THC percentages. “We need to stop looking at THC percentages and more at the terpenes,” he declared.

For now, the only known remedy for CHS is complete abstinence from cannabis. As more individuals share their experiences, the need for further research into this troubling condition becomes increasingly urgent. With the growing popularity of cannabis, public health officials and advocates alike are advocating for a better understanding of its effects to ensure safe usage.

Stay tuned for more updates on this developing story, as researchers continue to investigate the complexities surrounding cannabinoid hyperemesis syndrome.